United States Patent No. 6,428,810 (“the ’810 patent”) to enable DRL to bring its proposed… The ‘810 Patent
14. On its face, the ’810 patent, entitled “Pharmaceutical…United States Patent and Trademark Office on
August 6, 2002. A copy of the ’810 patent is attached hereto…records at the United States Patent and Trademark Office, the
’810 patent has been assigned to Defendant…creates jurisdiction so that the patent and NDA holder may commence a patent
infringement action within 45
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.